| Health Economic Evaluation of Influenza and Pneumococcal Vaccination in COPD Patients (NCT07640841) | Jiangsu Province Centers for Disease Control and Prevention | 2026-06-15 |
| Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination (NCT07530679) | Jiangsu Province Centers for Disease Control and Prevention | 2026-04-12 |
| Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine (NCT07585370) | Jiangsu Province Centers for Disease Control and Prevention | 2026-03-06 |
| Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine (NCT07232745) | Jiangsu Province Centers for Disease Control and Prevention | 2025-10-12 |
| The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine (NCT06609811) | Jiangsu Province Centers for Disease Control and Prevention | 2024-09-21 |
| Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants (NCT06605755) | Jiangsu Province Centers for Disease Control and Prevention | 2024-09-05 |
| Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (NCT07035054) | Jiangsu Province Centers for Disease Control and Prevention | 2024-04-20 |
| PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (NCT07025876) | Jiangsu Province Centers for Disease Control and Prevention | 2023-11-18 |
| Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults (NCT05855408) | Jiangsu Province Centers for Disease Control and Prevention | 2023-05-18 |
| Safety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose Booster (NCT07672626) | Jiangsu Province Centers for Disease Control and Prevention | 2022-07-19 |
| Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine (NCT05303584) | Jiangsu Province Centers for Disease Control and Prevention | 2022-04-23 |
| Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine (NCT05204589) | Jiangsu Province Centers for Disease Control and Prevention | 2022-01-22 |
| Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients (NCT05148949) | Jiangsu Province Centers for Disease Control and Prevention | 2021-12-22 |
| A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months (NCT05212623) | Jiangsu Province Centers for Disease Control and Prevention | 2021-10-26 |
| A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years (NCT05144464) | Jiangsu Province Centers for Disease Control and Prevention | 2021-09-19 |
| A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years (NCT05313893) | Jiangsu Province Centers for Disease Control and Prevention | 2021-09-11 |
| Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults (NCT04952727) | Jiangsu Province Centers for Disease Control and Prevention | 2021-08-26 |
| Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector) (NCT04892459) | Jiangsu Province Centers for Disease Control and Prevention | 2021-05-25 |
| Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine (NCT04833101) | Jiangsu Province Centers for Disease Control and Prevention | 2021-04-07 |
| Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells) (NCT04813562) | Jiangsu Province Centers for Disease Control and Prevention | 2021-03-23 |
| Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults (NCT05313646) | Jiangsu Province Centers for Disease Control and Prevention | 2021-03-08 |
| Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells) (NCT04718467) | Jiangsu Province Centers for Disease Control and Prevention | 2021-02-01 |
| A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) (NCT04640402) | Jiangsu Province Centers for Disease Control and Prevention | 2020-11-17 |
| Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) (NCT04636333) | Jiangsu Province Centers for Disease Control and Prevention | 2020-10-30 |
| The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine (NCT04568811) | Jiangsu Province Centers for Disease Control and Prevention | 2020-09-26 |
| Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell) (NCT04530656) | Jiangsu Province Centers for Disease Control and Prevention | 2020-08-28 |
| A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults (NCT03966040) | Jiangsu Province Centers for Disease Control and Prevention | 2019-05-16 |
| Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71 (NCT03582761) | Jiangsu Province Centers for Disease Control and Prevention | 2019-05-01 |
| Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in China (NCT03893747) | Jiangsu Province Centers for Disease Control and Prevention | 2019-04-01 |
| Immunity Duration of Rabies Vaccine and Booster Dose Effects at 10 Years Post-primary Vaccination (NCT03774628) | Jiangsu Province Centers for Disease Control and Prevention | 2018-08-01 |
| Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine (NCT06209398) | Jiangsu Province Centers for Disease Control and Prevention | 2018-05-24 |
| Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine. (NCT03902054) | Jiangsu Province Centers for Disease Control and Prevention | 2017-12-28 |
| Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib) (NCT04264546) | Jiangsu Province Centers for Disease Control and Prevention | 2017-11-24 |
| Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age (NCT03314103) | Jiangsu Province Centers for Disease Control and Prevention | 2017-10-06 |
| Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine . (NCT03971370) | Jiangsu Province Centers for Disease Control and Prevention | 2017-09-10 |